Postpartum hemorrhage (PPH) is treated through a rapid, layered approach that starts with medications to contract the uterus and escalates to physical interventions, blood transfusions, or surgery depending on how the body responds. PPH is defined as blood loss of 1,000 mL or more within 24 hours of delivery, or bleeding accompanied by signs of dangerously low blood volume like dizziness, rapid heart rate, or dropping blood pressure. Treatment moves fast because every minute of uncontrolled bleeding increases risk.
Why the Bleeding Happens
Understanding the cause of PPH matters because it determines which treatment works. Clinicians use a framework called the “4 Ts” to identify the source: tone, trauma, tissue, and thrombin (clotting problems). Of these, uterine atony is by far the most common. After delivery, the uterus is supposed to contract tightly to clamp down on the blood vessels where the placenta was attached. When those muscles stay soft and weak instead of squeezing shut, bleeding pours from the open vessels.
The other causes are less frequent but just as urgent. Trauma refers to tears or injuries to the vagina, cervix, or uterus during delivery. Retained tissue means part of the placenta didn’t fully separate from the uterine wall. And clotting disorders prevent the blood from forming the clots it needs to stop bleeding on its own. Sometimes, pooled blood collects in a hidden area and the injured tissue continues to bleed hours or even days after delivery.
Medications That Contract the Uterus
The first line of treatment for PPH caused by uterine atony is a class of drugs called uterotonics, which force the uterine muscles to contract. Oxytocin is the standard choice. For active bleeding, it’s given as a slow injection into a vein, with a repeat dose if needed, or as a continuous drip. This is the same hormone the body naturally produces during labor, but given at higher concentrations to trigger stronger contractions.
If oxytocin alone doesn’t control the bleeding, additional medications are added. Ergometrine is a powerful uterine stimulant given by injection, though it can’t be used in people with high blood pressure. Misoprostol, a tablet placed under the tongue, offers another option and is especially valuable in settings where injectable drugs or refrigeration aren’t available. These medications are often used in combination when a single drug isn’t enough.
Tranexamic Acid: Timing Is Critical
Alongside uterotonics, a clot-stabilizing medication called tranexamic acid (TXA) is now a standard part of PPH treatment. It works by preventing the body from breaking down the blood clots that are trying to seal off bleeding vessels. Research pooling data from large trials found that giving TXA immediately nearly doubled the odds of surviving a hemorrhage compared to placebo. For every 15 minutes of delay, the benefit dropped by about 10%. That steep decline makes early administration one of the most time-sensitive decisions in PPH care.
Uterine Massage and Balloon Tamponade
While medications are being given, the care team typically begins bimanual uterine massage, firmly pressing on the uterus through the abdomen and sometimes from inside the vagina to physically stimulate contraction. If the uterus still won’t firm up, the next step is balloon tamponade.
This involves inserting a balloon catheter into the uterus and inflating it with saline. The balloon pushes outward against the uterine wall, compressing the bleeding vessels from the inside. Think of it like applying direct pressure to a wound, but from within the uterus itself. Success rates in case series have ranged from 57% after cesarean delivery to 100% after vaginal delivery. In one study, the rate of severe ongoing hemorrhage dropped from about 17% without the balloon to just 2.4% with it. The balloon is typically left in place for several hours while the medical team monitors blood loss.
Blood Transfusions and Volume Replacement
When blood loss is severe, replacing what’s been lost becomes just as important as stopping the source. Hospitals activate what’s called a massive transfusion protocol, delivering packed red blood cells alongside plasma and platelets to restore both volume and clotting ability. The exact ratios of these blood products vary. Current evidence suggests that following a rigid, fixed ratio matters less than adjusting the mix based on how the patient is actually responding, including lab results and vital signs in real time. The goal is to prevent the dangerous cycle where massive blood loss depletes clotting factors, which causes more bleeding, which depletes them further.
In resource-limited settings where blood products may not be immediately available, a device called a non-pneumatic anti-shock garment can buy critical time. It’s a neoprene and Velcro suit that wraps tightly around the lower body and abdomen, compressing blood vessels to redirect blood flow toward the heart and brain. The World Health Organization recommends it as a bridge in facilities where delays in definitive treatment are common.
Surgical Options When Other Treatments Fail
If medications and balloon tamponade don’t control the bleeding, surgical interventions are the next step. One widely used technique is the B-Lynch suture, sometimes called a “brace suture.” A surgeon threads suture material around the uterus in a specific pattern that physically compresses it, similar to how squeezing a sponge stops water from flowing through it. The suture holds the uterine walls together tightly enough to close off bleeding vessels. This approach preserves the uterus and future fertility.
Another option is uterine artery embolization, performed by an interventional radiologist rather than a surgeon. A catheter is threaded through a blood vessel in the groin up to the arteries feeding the uterus, where tiny particles are injected to block blood flow to the bleeding site. A study following 92 women who underwent this procedure for PPH found that among those who later wanted to become pregnant, about 87% successfully conceived. However, about 41% of those who carried to term experienced PPH again in a subsequent delivery, and roughly 20% of all patients reported changes to their menstrual cycle after the procedure. So while it effectively stops acute bleeding and preserves fertility, it does carry meaningful implications for future pregnancies.
Hysterectomy as a Last Resort
When all other measures fail to control life-threatening hemorrhage, emergency hysterectomy (removing the uterus) is the definitive treatment. This permanently stops uterine bleeding and eliminates the possibility of future pregnancies. It’s reserved for situations where the bleeding simply cannot be controlled by any other means, or when structural problems like a deeply invasive placenta make the uterus unsalvageable. While it’s the outcome everyone works to avoid, it can be lifesaving when the situation demands it.
How Treatment Escalates in Practice
PPH treatment isn’t a single decision. It’s a sequence that unfolds over minutes to hours, with each step triggered by the response to the last. In practice, a typical escalation looks something like this:
- First minutes: Uterine massage, oxytocin, and tranexamic acid, all started nearly simultaneously.
- If bleeding continues: Additional uterotonic medications are added and blood products are ordered.
- If still uncontrolled: Balloon tamponade is placed while preparations are made for possible surgery.
- If tamponade fails: Compression sutures, artery embolization, or hysterectomy, depending on the cause, the facility’s capabilities, and the clinical picture.
Multiple interventions often happen in parallel rather than one at a time. A patient might receive tranexamic acid, a second uterotonic, and a blood transfusion all while a balloon is being placed. The speed and overlap of these steps reflect how quickly PPH can become dangerous, and why hospitals rehearse these protocols regularly so that every member of the team knows what comes next.